Oral Penicillin Challenge and Allergy De-labeling in Children

Stopped early · Phase 4

Conditions studied: Penicillin Allergy

In brief

The primary purpose of this study is to investigate the portion of penicillin allergy labels that are not true allergies using oral amoxicillin challenges among pediatric patients. The secondary purpose is to evaluate the safety and feasibility of administering oral penicillin allergy challenges in the Pediatric Emergency Department.

Key facts

Study ID

NCT05563610

Run by

Phoenix Children's Hospital

People needed

31

Starts

2022-09-26

Expected to finish

2024-06-12

Last updated by the study team

2024-06-14

Who can join

Age: 2 and older, up to 17. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients in the pediatric emergency department who are 2-17 yo and labeled as penicillin-allergic (including amoxicillin or other penicillin allergies)
• Patients at low risk of anaphylaxis as determined by the study questionnaire
• Patients who would normally be prescribed amoxicillin, amoxicillin-clavulanate or another penicillin for their current bacterial infection, including otitis media, Group A Streptococcal pharyngitis, pneumonia. sinusitis, dog and cat bite wounds, regimens for Helicobacter pylori eradication, or other acute infections deemed susceptible.
• Patients who are interested in participating
• Patients who have an acceptable surrogate to give consent on the subject's behalf
• Patients whose surrogate (parent/caregiver) speaks English or Spanish

You may not qualify if…

• Patients who are uninterested in participating, or their parents/caregivers are not interested in having them participate
• Patients who have multiple drug allergies

Where it is running

• Phoenix Children's — Phoenix, Arizona, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.